Skip to main content
Addgene

pLenti-eGFP-dSaCas9-blast
(Plasmid #191653)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 191653 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pLenti- V6.3 Ultra
  • Backbone manufacturer
    Addgene #106172
  • Vector type
    Mammalian Expression, Lentiviral, CRISPR
  • Selectable markers
    Blasticidin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    eGFP-T2A-dSaCas9
  • Alt name
    SadCas9
  • Alt name
    dSaCas9
  • Species
    Synthetic
  • Promoter CMV
  • Tag / Fusion Protein
    • 3XFLAG (C terminal on insert)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site NheI (not destroyed)
  • 3′ cloning site EcoRI (not destroyed)
  • 5′ sequencing primer CMV-F
  • (Common Sequencing Primers)

Resource Information

  • A portion of this plasmid was derived from a plasmid made by
    Sa-dCas9-NLS-3xFLAG/pcDNA3.1 (Addgene plasmid #98041)

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pLenti-eGFP-dSaCas9-blast was a gift from Moshe Szyf (Addgene plasmid # 191653 ; http://n2t.net/addgene:191653 ; RRID:Addgene_191653)
  • For your References section:

    The PROTECTOR strategy employs dCas orthologs to sterically shield off-target sites from CRISPR/Cas activity. Sapozhnikov DM, Szyf M. Sci Rep. 2023 Feb 9;13(1):2280. doi: 10.1038/s41598-023-29332-2. 10.1038/s41598-023-29332-2 PubMed 36759683